NT_1170x120_1-11-18

0.1%|2.5%

Glenmark receives ANDA approval for adapalene and benzoyl peroxide gel

Glenmark receives ANDA approval for adapalene and benzoyl peroxide gel

MUMBAI, India —  Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for adapalene and benzoyl peroxide gel, 0.1% 2.5%, the generic version of Epiduo Gel, 0.1% 2.5%, of Galderma Laboratories. According to IQVIA sales data for the 12 month period ending September 2019, the Epiduo Gel,  0.1%|2.5%